» Articles » PMID: 677270

Ultrastructural Evaluation of the Effects of 1,25-dihydroxyvitamin D3 on Bone of Thyroparathyroidectomized Rats Fed a Low-calcium Diet

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 1978 Aug 1
PMID 677270
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Thyroparathyroidectomized rats fed a low-calcium-normal-phosphorus diet were administered 1 or 5 units of 1,25-dihydroxyvitamin D3-(1,25-[OH]2D3) or placebo daily for 7 days. 1,25-(OH)2D3 elevated serum and urine calcium and decreased serum phosphorus. Rats given 1 unit of 1,25-(OH)2D3 had increased numbers of osteoclasts in metaphyseal trabeculae, Ultrastructurally, osteoclasts, osteoblasts, and osteocytes in rats given 1 unit of 1,25-(OH)2D3, were similar to those in rats given placebo. In rats given 5 units of 1,25-(OH)2D3, osteoclasis was markedly increased. Osteoblasts were more numerous and interpreted to be active in matrix production and mineralization. Lamellated electron-dense bodies were observed adjacent to the plasma membranes of less active osteoblasts and were interpreted to be modified matrix. Most osteocytes in rats given 5 units of 1,25-(OH)2D3 were indistinguishable from osteocytes in rats given placebo. However,the pericellular space of some osteocytes in rats given 5 units of 1,25-(OH)2D3 contained electron-dense granular deposits that were interpreted to be calcium phosphate. It is concluded that 1,25-(OH)2D3 is able to significantly elevate serum calcium independent of dietary calcium, parathyroid hormone, and calcitonin primarily by increasing ostoeclasis with minimal dependence on osteocytic osteolysis.

Citing Articles

Vitamin D and orthodontics: an insight review.

Almoammar K Clin Cosmet Investig Dent. 2018; 10:165-170.

PMID: 30104902 PMC: 6072678. DOI: 10.2147/CCIDE.S157840.


Osteoclast formation in response to intraperitoneal injection of 1 alpha-hydroxycholecalciferol in mice.

Tinkler S, Williams D, Johnson N J Anat. 1981; 133(Pt 1):91-7.

PMID: 7319902 PMC: 1167727.


Histomorphometric evaluation of the effects of intermittent 1,25-dihydroxycholecalciferol administration on cortical bone remodeling in adult dogs.

High W, Capen C, Black H Am J Pathol. 1981; 104(1):41-9.

PMID: 6894823 PMC: 1903742.


Continuous infusion of 1,25-dihydroxyvitamin D3 stimulates bone turnover in the normal young mouse.

Marie P, Travers R Calcif Tissue Int. 1983; 35(4-5):418-25.

PMID: 6688545 DOI: 10.1007/BF02405070.


24,25(OH)2D3, bone formation, and bone resorption in vitamin D-deficient, azotemic rats.

Goodman W, Baylink D, Sherrard D Calcif Tissue Int. 1984; 36(2):206-13.

PMID: 6430503 DOI: 10.1007/BF02405319.


References
1.
CAULFIELD J, SCHRAG P . ELECTRON MICROSCOPIC STUDY OF RENAL CALCIFICATION. Am J Pathol. 1964; 44:365-81. PMC: 1907019. View

2.
Scarpelli D . EXPERIMENTAL NEPHROCALCINOSIS. A BIOCHEMICAL AND MORPHOLOGIC STUDY. Lab Invest. 1965; 14:123-41. View

3.
Giacomelli F, SPIRO D, Wiener J . A STUDY OF METASTATIC RENAL CALCIFICATION AT THE CELLULAR LEVEL. J Cell Biol. 1964; 22:189-206. PMC: 2106482. DOI: 10.1083/jcb.22.1.189. View

4.
Rasmussen H, Deluca H, Arnaud C, Hawker C, VONSTEDINGK M . THE RELATIONSHIP BETWEEN VITAMIN D AND PARATHYROID HORMONE. J Clin Invest. 1963; 42:1940-6. PMC: 289482. DOI: 10.1172/JCI104880. View

5.
Reynolds J, Pavlovitch H, BALSAN S . 1,25-Dihydroxycholecalciferol increases bone resorption in thyroparathyroidectomised mice. Calcif Tissue Res. 1976; 21(3):207-12. DOI: 10.1007/BF02547397. View